调查患者在多大程度上应控制用于研究的患者记录的访问权限:使用公民陪审团的审议过程
Investigating the Extent to Which Patients Should Control Access to Patient Records for Research: A Deliberative Process Using Citizens' Juries.
作者信息
Tully Mary P, Bozentko Kyle, Clement Sarah, Hunn Amanda, Hassan Lamiece, Norris Ruth, Oswald Malcolm, Peek Niels
机构信息
Health E-Research Centre, Division of Imaging, Informatics and Data Sciences, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom.
Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom.
出版信息
J Med Internet Res. 2018 Mar 28;20(3):e112. doi: 10.2196/jmir.7763.
BACKGROUND
The secondary use of health data for research raises complex questions of privacy and governance. Such questions are ill-suited to opinion polling where citizens must choose quickly between multiple-choice answers based on little information.
OBJECTIVE
The aim of this project was to extend knowledge about what control informed citizens would seek over the use of health records for research after participating in a deliberative process using citizens' juries.
METHODS
Two 3-day citizens' juries, of 17 citizens each, were convened to reflect UK national demographics from 355 eligible applicants. Each jury addressed the mission "To what extent should patients control access to patient records for secondary use?" Jurors heard from and questioned 5 expert witnesses (chosen either to inform the jury, or to argue for and against the secondary use of data), interspersed with structured opportunities to deliberate among themselves, including discussion and role-play. Jurors voted on a series of questions associated with the jury mission, giving their rationale. Individual views were polled using questionnaires at the beginning and at end of the process.
RESULTS
At the end of the process, 33 out of 34 jurors voted in support of the secondary use of data for research, with 24 wanting individuals to be able to opt out, 6 favoring opt in, and 3 voting that all records should be available without any consent process. When considering who should get access to data, both juries had very similar rationales. Both thought that public benefit was a key justification for access. Jury 1 was more strongly supportive of sharing patient records for public benefit, whereas jury 2 was more cautious and sought to give patients more control. Many jurors changed their opinion about who should get access to health records: 17 people became more willing to support wider information sharing of health data for public benefit, whereas 2 moved toward more patient control over patient records.
CONCLUSIONS
The findings highlight that, when informed of both risks and opportunities associated with data sharing, citizens believe an individual's right to privacy should not prevent research that can benefit the general public. The juries also concluded that patients should be notified of any such scheme and have the right to opt out if they so choose. Many jurors changed their minds about this complex policy question when they became more informed. Many, but not all, jurors became less skeptical about health data sharing, as they became better informed of its benefits and risks.
背景
将健康数据二次用于研究引发了复杂的隐私和治理问题。这类问题并不适合进行民意调查,因为在民意调查中,公民必须在信息有限的情况下,在多项选择题答案中迅速做出选择。
目的
本项目的目的是拓展相关知识,即公民在参与公民陪审团审议过程后,对于将健康记录用于研究希望获得何种控制权。
方法
召集了两个为期3天的公民陪审团,每个陪审团有17名公民,从355名符合条件的申请人中选出,以反映英国的全国人口特征。每个陪审团的任务是“患者应在多大程度上控制患者记录用于二次使用的访问权限?”陪审员听取了5名专家证人的陈述并进行提问(这些专家证人要么为陪审团提供信息,要么就数据的二次使用进行正反两方面的辩论),期间穿插着让陪审员自行审议的结构化机会,包括讨论和角色扮演。陪审员就与陪审团任务相关的一系列问题进行投票,并给出理由。在过程开始和结束时,通过问卷调查收集个人观点。
结果
在过程结束时,34名陪审员中有33人投票支持将数据二次用于研究,其中24人希望个人能够选择退出,6人支持选择加入,3人投票认为所有记录无需任何同意程序即可使用。在考虑谁应该有权访问数据时,两个陪审团的理由非常相似。双方都认为公共利益是访问的关键理由。陪审团1更强烈支持为了公共利益共享患者记录,而陪审团2则更为谨慎,寻求给予患者更多控制权。许多陪审员改变了他们对于谁应该有权访问健康记录的看法:17人更愿意支持为了公共利益更广泛地共享健康数据信息,而2人则倾向于让患者对患者记录有更多控制权。
结论
研究结果表明,当了解到与数据共享相关的风险和机遇时,公民认为个人的隐私权不应阻碍能够造福公众的研究。陪审团还得出结论,应将任何此类计划通知患者,并且患者有权选择退出。当了解得更多时,许多陪审员对这个复杂的政策问题改变了看法。随着对健康数据共享的益处和风险了解得更多,许多(但不是所有)陪审员对其的怀疑减少了。